Irvine-based Ivantis, a developer of medical devices for the treatment of glaucoma, announced today that it has raised $17M in a new, second round of funding. The round came from New Enterprise Associates and Delphi Ventures. Ivantis said it will use the new funding to expand clinical activities. Ivantis develops a medical device used to treat primary open angle glaucoma. More information »